Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Renal Cell Carcinoma
Interventions
DRUG

Temsirolimus (pre surgery)

Temsirolimus will be given to patients 12 weeks prior to surgery (with a one week off period right before the surgery date).

Trial Locations (1)

L8N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

McMaster University

OTHER

collaborator

Pfizer

INDUSTRY

lead

St. Joseph's Healthcare Hamilton

OTHER